Zacks Research Issues Pessimistic Forecast for WTW Earnings

Willis Towers Watson Public Limited (NASDAQ:WTW - Free Report) - Analysts at Zacks Research reduced their Q1 2025 EPS estimates for Willis Towers Watson Public in a research note issued to investors on Wednesday, April 9th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $3.22 per share for the quarter, down from their prior forecast of $3.31. The consensus estimate for Willis Towers Watson Public's current full-year earnings is $17.32 per share. Zacks Research also issued estimates for Willis Towers Watson Public's Q2 2025 earnings at $2.75 EPS, Q3 2025 earnings at $3.08 EPS, Q4 2025 earnings at $7.89 EPS, FY2025 earnings at $16.94 EPS, Q1 2026 earnings at $4.00 EPS, Q2 2026 earnings at $3.63 EPS, Q3 2026 earnings at $3.38 EPS, Q4 2026 earnings at $7.93 EPS, FY2026 earnings at $18.95 EPS, Q1 2027 earnings at $4.63 EPS and FY2027 earnings at $22.20 EPS.

Willis Towers Watson Public (NASDAQ:WTW - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported $8.13 EPS for the quarter, beating analysts' consensus estimates of $8.01 by $0.12. Willis Towers Watson Public had a positive return on equity of 20.02% and a negative net margin of 0.99%. The business had revenue of $3.04 billion during the quarter, compared to analysts' expectations of $3.05 billion. During the same quarter in the prior year, the firm earned $7.44 earnings per share. The business's revenue was up 4.2% compared to the same quarter last year.

A number of other equities analysts have also weighed in on the company. Barclays boosted their price objective on Willis Towers Watson Public from $302.00 to $316.00 and gave the stock an "underweight" rating in a research note on Friday, April 11th. Keefe, Bruyette & Woods reiterated an "outperform" rating and set a $387.00 target price on shares of Willis Towers Watson Public in a research report on Wednesday, April 9th. Jefferies Financial Group dropped their price target on shares of Willis Towers Watson Public from $373.00 to $371.00 and set a "buy" rating on the stock in a research note on Friday, April 11th. Evercore ISI raised shares of Willis Towers Watson Public from an "in-line" rating to an "outperform" rating and upped their price target for the company from $357.00 to $373.00 in a report on Wednesday, January 8th. Finally, UBS Group raised shares of Willis Towers Watson Public from a "neutral" rating to a "buy" rating and increased their price target for the stock from $344.00 to $395.00 in a research note on Tuesday, March 18th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, Willis Towers Watson Public has an average rating of "Moderate Buy" and a consensus target price of $346.38.

Willis Towers Watson Public Price Performance

WTW traded up $0.71 on Friday, reaching $327.87. 238,044 shares of the company's stock were exchanged, compared to its average volume of 561,174. The stock has a market cap of $32.69 billion, a PE ratio of -327.87, a P/E/G ratio of 2.95 and a beta of 0.68. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.98 and a quick ratio of 1.72. Willis Towers Watson Public has a twelve month low of $245.04 and a twelve month high of $344.14. The stock's fifty day moving average price is $327.11 and its 200-day moving average price is $316.19.

Willis Towers Watson Public Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Monday, March 31st were issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 1.12%. The ex-dividend date of this dividend was Monday, March 31st. This is an increase from Willis Towers Watson Public's previous quarterly dividend of $0.88. Willis Towers Watson Public's payout ratio is presently -368.00%.

Insiders Place Their Bets

In other news, insider Julie Jarecke Gebauer sold 3,384 shares of the business's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $335.77, for a total transaction of $1,136,245.68. Following the transaction, the insider now directly owns 74,417 shares in the company, valued at $24,986,996.09. The trade was a 4.35 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.32% of the company's stock.

Institutional Investors Weigh In On Willis Towers Watson Public

Several large investors have recently made changes to their positions in WTW. JPMorgan Chase & Co. increased its position in Willis Towers Watson Public by 24.9% during the third quarter. JPMorgan Chase & Co. now owns 187,267 shares of the company's stock worth $55,156,000 after buying an additional 37,340 shares during the last quarter. Everence Capital Management Inc. acquired a new position in Willis Towers Watson Public during the fourth quarter valued at approximately $993,000. Sanctuary Advisors LLC raised its position in shares of Willis Towers Watson Public by 2.7% in the fourth quarter. Sanctuary Advisors LLC now owns 4,135 shares of the company's stock valued at $1,364,000 after purchasing an additional 109 shares during the period. Nomura Asset Management Co. Ltd. boosted its holdings in shares of Willis Towers Watson Public by 5.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 30,835 shares of the company's stock worth $9,082,000 after buying an additional 1,660 shares during the period. Finally, World Investment Advisors LLC acquired a new position in Willis Towers Watson Public in the 3rd quarter valued at $39,999,000. Institutional investors own 93.09% of the company's stock.

Willis Towers Watson Public Company Profile

Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments: Health, Wealth & Career and Risk & Broking. The company offers strategy and design consulting, plan management service and support, broking and administration services for health, wellbeing, and other group benefit program, including medical, dental, disability, life, voluntary benefits and other coverages; actuarial support, plan design, and administrative services for pension and retirement savings plans; retirement consulting services and solutions; and integrated solutions that consists of investment discretionary management, pension administration, core actuarial, and communication and change management assistance services.